MedPath

南京驯鹿生物医药有限公司

Ownership
-
Established
2019-12-03
Employees
-
Market Cap
-
Website
https://cn.iasobio.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Equecabtagene Autoleucel Injection

Product Name
福可苏
Approval Number
国药准字S20230040
Approval Date
Jun 30, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.